Impacto de la inercia terapéutica y del grado de adherencia al tratamiento en los objetivos de control en personas con diabetes

2017, Standards of medical care in diabetes, Diabetes Care, 40, S48 Vinagre, 2012, Control of glycemia and cardiovascular risk factors in patients with type2 diabetes in primary care in Catalonia (Spain), Diabetes Care., 35, 774, 10.2337/dc11-1679 Casagrande, 2013, The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010, Diabetes Care., 36, 2271, 10.2337/dc12-2258 Vinagre, 2013, Situación actual del control de la diabetes mellitus tipo2 en España. Identificación de las principales barreras en la práctica clínica diaria, Med Clin (Barc)., 141, 3, 10.1016/S0025-7753(13)70056-3 Phillips, 2001, Clinical inertia, Ann Intern Med., 135, 825, 10.7326/0003-4819-135-9-200111060-00012 Scheen, 2010, Targeting inertia and therapy non-compliance: New challenge for improving medical practice performance, Rev Med Liege., 65, 229 López-Simarro, 2012, Inertia and treatment compliance in patients with type2 diabetes in primary care, Med Clin (Barc)., 138, 377, 10.1016/j.medcli.2011.07.023 López-Simarro, 2016, Concordance between two methods in measuring treatment adherence in patients with type2 diabetes, Patient Prefer Adherence, 10, 743, 10.2147/PPA.S105073 2010, Clinical Practice Recommendations 2010. Executive summary: Standards of medical care in diabetes-2010, Diabetes Care., 33, S4 Schmittdiel, 2008, Why don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification, J Gen Intern Med., 23, 588, 10.1007/s11606-008-0554-8 Farmer, 2016, MASTERMIND Consortium. Adherence to oral glucose-lowering therapies and associations with 1-year HbA1c: A retrospective cohort analysis in a large primary care database, Diabetes Care, 39, 258, 10.2337/dc15-1194 Scheen, 2010, Targeting inertia and therapy non-compliance: New challenge for improving medical practice performance, Rev Med Liege., 65, 229 Vernet Vernet, 2016, Inercia terapéutica en el manejo de pacientes con diabetes mellitus tipo2 en el ámbito de la Atención Primaria, Semergen., 42, 152, 10.1016/j.semerg.2015.02.013 Grant, 2007, Relationship between patient medication adherence and subsequent clinical inertia in type2 diabetes glycemic management, Diabetes Care., 30, 807, 10.2337/dc06-2170 Heisler, 2008, When more is not better: Treatment intensification among hypertensive patients with poor medication adherence, Circulation., 117, 2884, 10.1161/CIRCULATIONAHA.107.724104 Pittman, 2012, Relation of statin nonadherence and treatment intensification, Am J Cardiol., 110, 1459, 10.1016/j.amjcard.2012.07.008 Ismail-Beigi, 2011, Individualizing glycemic targets in type2 diabetes mellitus: Implications of recent clinical trials, Ann Intern Med, 154, 554, 10.7326/0003-4819-154-8-201104190-00007 Teoh, 2011, Should A1C targets be individualized for all people with diabetes? Arguments for and against, Diabetes Care., 34, S191, 10.2337/dc11-s217 Mancera-Romero, 2016, Satisfacción de las personas con diabetes mellitus tipo 2 tras iniciar tratamiento con insulina, Semergen., 42, 298, 10.1016/j.semerg.2015.06.002 Kerr, 2008, The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure, Ann Intern Med., 148, 717, 10.7326/0003-4819-148-10-200805200-00004 Daugherty, 2012, The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension, Hypertension., 60, 303, 10.1161/HYPERTENSIONAHA.112.192096 Vigen, 2012, A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures, Circ Cardiovasc Qual Outcomes., 5, 276, 10.1161/CIRCOUTCOMES.112.965665